Covid 19, Hearing Loss and Monitoring for Ototoxicity

Expiry Date
: 31/10/2025
CPD Units
: 3.00 Points
: Not yet rated.

These articles look at the drugs used in the treatment for Covid 19, that could have ototoxic effects. It also looks at the best audiological test to monitor for ototoxicity.

Keywords: Covid 19, Hearing loss, Ototoxicity

Educational Objectives

Educational Aim:
The aim of these articles is to identify medications that are being used in the treatment of Covid-19 and have ototoxic effects. It also suggests using Distortion Product Acoustic Emissions for monitoring purpose. This test picks up threshold shift earlier than traditional Pure Tone Audiometry, is objective and does not require the co-operation of a patient.

Editor's comments:
The pandemic continues, and saving lives remains the primary concern. Some drugs used in the treatment of Covid 19 can have ototoxic effects. Audiologists need to be aware of all medication used in the treatment of Covid 19, and their potential ototoxic effects. Audiologist also need to play a role in monitoring hearing for ototoxicity.

Educational Outcomes:
Upon completion of this module practitioners should have a clear understanding of:

  1. The definition of ototoxicity 
  2. The effect of ototoxic medications 
  3. Medications that can have ototoxic effects 
  4. The need for monitoring 
  5. Different audiological tests 
  6. The use of Distortion Product Otoacoustic Emissions 
  7. The potential use for UHF Otoacoustic Emissions in the future.

            Instructions for this Module

            • Read the supplied reading material and complete the quiz that follows;
            • You have three attempts to pass the quiz;
            • The pass grade is 70%;
            • You need to pass the quiz to claim your CPD certificate;
            • Please click on the CPD certificate link below to claim your CPD certificate and to update your CPD Manager.

            If you need any assistance to complete this module, please Contact us